Vertex Pharmaceuticals (VRTX) Change in Account Payables (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly Change in Account Payables of $35.6 million for Q1 2026, up 35.88% year-over-year from $26.2 million in Q1 2025, and down 7.05% quarter-over-quarter from $38.3 million in Q4 2025.
Vertex Pharmaceuticals (VRTX) Change in Account Payables (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Change in Account Payables history runs 18 years deep, the most recent figure standing at $35.6 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 35.88% year-over-year to $35.6 million; the TTM figure through Mar 2026 stood at $46.2 million (down 38.89% YoY), while the FY2025 annual figure was $36.8 million, down 25.66% from the prior year.
- Change in Account Payables for Q1 2026 stood at $35.6 million, down from $38.3 million in the prior quarter.
- The five-year high for Change in Account Payables was $159.9 million in Q4 2022, with the low at -$69.9 million in Q3 2022.
- The 5-year median for Change in Account Payables is $9.2 million (2023), against an average of $17.1 million.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables tumbled 3139.13% in 2022, then surged 26100.0% in 2025.
- Vertex Pharmaceuticals' Change in Account Payables stood at $159.9 million in 2022, then tumbled by 119.89% to -$31.8 million in 2023, then jumped by 126.42% to $8.4 million in 2024, then soared by 355.95% to $38.3 million in 2025, then retreated by 7.05% to $35.6 million in 2026.
- Business Quant data shows VRTX's Change in Account Payables at $35.6 million in Q1 2026, $38.3 million in Q4 2025, and -$35.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -66.70 Mn |
| Jun 30, 2026 | -66.70 Mn |
| Mar 31, 2026 | 35.60 Mn |
| Mar 31, 2026 | 35.60 Mn |
| Dec 31, 2025 | 38.30 Mn |
| Dec 31, 2025 | 38.30 Mn |
| Sep 30, 2025 | -35.30 Mn |
| Sep 30, 2025 | -35.30 Mn |
| Jun 30, 2025 | 7.60 Mn |
| Jun 30, 2025 | 7.60 Mn |
| Mar 31, 2025 | 26.20 Mn |
| Mar 31, 2025 | 26.20 Mn |
| Dec 31, 2024 | 8.40 Mn |
| Dec 31, 2024 | 8.40 Mn |
| Sep 30, 2024 | 66.10 Mn |
| Sep 30, 2024 | 66.10 Mn |
| Jun 30, 2024 | -25.10 Mn |
| Jun 30, 2024 | -25.10 Mn |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |